Andrew J. Page

Citée par

	Toutes	Depuis 2020
Citations	33762	29974
indice h	64	59
indice i10	135	130

10000

5000

2500

7500

20152016201720182019202020212022202320242025143 387 618 838 1294 1803 7683 9031 6067 4692 528

Accès public

Tout afficher

183 articles

0 article

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Jacqueline A. KeanePathogen Genomics IT ConsultantAdresse e-mail validée de cambridgebioinformatics.com
Thomas ConnorProfessor, Cardiff University ; Head of Public Health Genomics, Public Health WalesAdresse e-mail validée de cardiff.ac.uk
Oliver EalesUniversity of MelbourneAdresse e-mail validée de unimelb.edu.au
Martin HuntNuffield Department of Medicine, University of Oxford / European Bioinformatics InstituteAdresse e-mail validée de ebi.ac.uk
Simon R. HarrisSenior Program Officer, Bill & Melinda Gates FoundationAdresse e-mail validée de sanger.ac.uk
Stephen BentleyWellcome Sanger InstituteAdresse e-mail validée de sanger.ac.uk
Thomas J. NaughtonNational University of Ireland MaynoothAdresse e-mail validée de cs.nuim.ie
Alison E MatherQuadram Institute BioscienceAdresse e-mail validée de quadram.ac.uk
Matthew HoldenUniversity of St AndrewsAdresse e-mail validée de st-andrews.ac.uk
Torsten SeemannThe University of MelbourneAdresse e-mail validée de unimelb.edu.au
Aidan DelaneyAdresse e-mail validée de ontologyengineering.org
David AanensenProfessor at Big Data Institute, University of OxfordAdresse e-mail validée de bdi.ox.ac.uk
Stephen BakerUniversity of CambridgeAdresse e-mail validée de medschl.cam.ac.uk
Nick CroucherImperial CollegeAdresse e-mail validée de imperial.ac.uk
Sandra ReuterMedical Center - University of Freiburg, Infection Prevention and ControlAdresse e-mail validée de uniklinik-freiburg.de
Daniel FalushShanghai Institute of Immunity and InfectionAdresse e-mail validée de ips.ac.cn
Robert A KingsleyGroup Leader at the Quadram Institute Bioscience, UKAdresse e-mail validée de quadram.ac.uk
Thomas KeaneResearch and Services Group LeaderAdresse e-mail validée de ebi.ac.uk
Susannah Jane SalterUniversity of CambridgeAdresse e-mail validée de cam.ac.uk
Nabil-Fareed AlikhanUniversity of OxfordAdresse e-mail validée de ndm.ox.ac.uk

Suivre

Andrew J. Page

Director of Technical Innovation, Theiagen Genomics

Adresse e-mail validée de quadram.ac.uk - Page d'accueil

Distributed Computing Pan-genomes Bioinformatics Microbial bioinformatics SARS-CoV-2


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Roary: rapid large-scale prokaryote pan genome analysis AJ Page, CA Cummins, M Hunt, VK Wong, S Reuter, MTG Holden, ... Bioinformatics 31 (22), 3691-3693, 2015	4779	2015
SARS-CoV-2 variants, spike mutations and immune escape WT Harvey, AM Carabelli, B Jackson, RK Gupta, EC Thomson, ... Nature Reviews Microbiology 19 (7), 409-424, 2021	3527	2021
Estimated transmissibility and impact of SARS-CoV-2 lineage B. 1.1. 7 in England NG Davies, S Abbott, RC Barnard, CI Jarvis, AJ Kucharski, JD Munday, ... Science 372 (6538), eabg3055, 2021	2676	2021
Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins NJ Croucher, AJ Page, TR Connor, AJ Delaney, JA Keane, SD Bentley, ... Nucleic acids research 43 (3), e15-e15, 2015	2228	2015
Assessing transmissibility of SARS-CoV-2 lineage B. 1.1. 7 in England E Volz, S Mishra, M Chand, JC Barrett, R Johnson, L Geidelberg, ... Nature 593 (7858), 266-269, 2021	1214	2021
SNP-sites: rapid efficient extraction of SNPs from multi-FASTA alignments AJ Page, B Taylor, AJ Delaney, J Soares, T Seemann, JA Keane, ... Microbial genomics 2 (4), e000056, 2016	1197*	2016
Evaluating the effects of SARS-CoV-2 Spike mutation D614G on transmissibility and pathogenicity EM Volz, V Hill, JT McCrone, A Price, D Jorgensen, A O'Toole, ... MedRxiv, 2020	1170	2020
SARS-CoV-2 evolution during treatment of chronic infection SA Kemp, DA Collier, RP Datir, IATM Ferreira, S Gayed, A Jahun, ... Nature 592 (7853), 277-282, 2021	1027	2021
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ... The Lancet Infectious Diseases 22 (1), 35-42, 2022	892	2022
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised controlled trial KRW Emary, T Golubchik, PK Aley, CV Ariani, B Angus, S Bibi, B Blane, ... The Lancet 397 (10282), 1351-1362, 2021	782	2021
Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies DA Collier, A De Marco, IATM Ferreira, B Meng, RP Datir, AC Walls, ... Nature 593 (7857), 136-141, 2021	735	2021
ARIBA: rapid antimicrobial resistance genotyping directly from sequencing reads M Hunt, AE Mather, L Sánchez-Busó, AJ Page, J Parkhill, JA Keane, ... Microbial genomics 3 (10), e000131, 2017	636	2017
Transmission of SARS-CoV-2 Lineage B. 1.1. 7 in England: Insights from linking epidemiological and genetic data E Volz, S Mishra, M Chand, JC Barrett, R Johnson, L Geidelberg, ... MedRxiv, 2020.12. 30.20249034, 2021	621	2021
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity EC Thomson, LE Rosen, JG Shepherd, R Spreafico, A da Silva Filipe, ... Cell 184 (5), 1171-1187. e20, 2021	598	2021
Emergence of an Extensively Drug-Resistant Salmonella enterica Serovar Typhi Clone Harboring a Promiscuous Plasmid Encoding Resistance to … EJ Klemm, S Shakoor, AJ Page, FN Qamar, K Judge, DK Saeed, ... MBio 9 (1), 10.1128/mbio. 00105-18, 2018	593	2018
Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events VK Wong, S Baker, DJ Pickard, J Parkhill, AJ Page, NA Feasey, ... Nature genetics 47 (6), 632-639, 2015	505	2015
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7 B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ... Cell reports 35 (13), 2021	467	2021
Dense genomic sampling identifies highways of pneumococcal recombination C Chewapreecha, SR Harris, NJ Croucher, C Turner, P Marttinen, ... Nature genetics 46 (3), 305-309, 2014	419	2014
Establishment & lineage dynamics of the SARS-CoV-2 epidemic in the UK L du Plessis, JT McCrone, AE Zarebski, V Hill, C Ruis, B Gutierrez, ... MedRxiv, 2020	407	2020
Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study MS Graham, CH Sudre, A May, M Antonelli, B Murray, T Varsavsky, ... The Lancet Public Health 6 (5), e335-e345, 2021	375	2021

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs